Day: November 9, 2020
NoHo Partners PlcNoHo Partners corporate website: www.noho.fi/enNoHo Partners consumer website: www.ravintola.fi/en
NoHo Partners Oyj:n taloudellinen tiedottaminen 2021
Written by Customer Service on . Posted in Public Companies.
NoHo Partners Oyj
Merus annonce ses résultats financiers pour le troisième trimestre et fait le point sur ses activités
Written by Customer Service on . Posted in Public Companies.
–Mise à jour des données cliniques du programme principal sur le Zenocutuzumab (« Zeno ») prévue pour le 2e trimestre 2021––Arrivée du programme MCLA-129 au stade clinique attendue courant 2021–UTRECHT, Pays-Bas et CAMBRIDGE, Mass., 09 nov. 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq : MRUS) (la « Société », « nous » ou « notre/nos »), une société d’oncologie au stade clinique qui développe des anticorps multispécifiques de pleine longueur innovants (Biclonics® et TriclonicsTM), a annoncé aujourd’hui ses résultats financiers pour le troisième trimestre clos le 30 septembre 2020 et fait le point sur ses activités.« Notre programme principal sur le Zeno pour le traitement des cancers avec fusion à la neuréguline 1 (NRG1) progresse régulièrement, et nous avons hâte de publier les données de l’essai clinique eNRGy et...
Merus gibt Finanzergebnisse für das dritte Quartal bekannt und legt ein Update zur Geschäftsentwicklung vor
Written by Customer Service on . Posted in Public Companies.
–Update der klinischen Daten und des Programms für den führenden Produktkandidaten Zenocutuzumab („Zeno“) im zweiten Quartal 2021–– Erstmaliger Einsatz von MCLA-129 in der klinischen Praxis voraussichtlich 2021 –UTRECHT, Niederlande, und CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) („Merus“, „die Gesellschaft“, „wir“ oder „unser“), ein Unternehmen aus dem Bereich der klinischen Onkologie, das innovative multispezifische volllange Antikörper (Biclonics® und Triclonics™) entwickelt, gab heute die Finanzergebnisse für das dritte Quartal zum 30. September 2020 bekannt und legte ein Update zur Geschäftsentwicklung vor.„Unser führender Produktkandidat Zeno für Krebserkrankungen mit Neuregulin-1-Fusionen (NRG1) wird kontinuierlich weiterentwickelt, und wir freuen uns, die Daten aus der klinischen Studie...
CORRECTION: Lilis Energy Announces Ameredev Texas LLC as Winning Bidder for Substantially all of Its Assets in Competitive Auction as Part of Chapter 11 Process
Written by Customer Service on . Posted in Public Companies.
FORT WORTH, Texas, Nov. 09, 2020 (GLOBE NEWSWIRE) — This press release corrects the prior press release dated November 8, 2020 solely with respect to the time and date of the Bankruptcy Court hearing to approve the proposed sale of assets.Lilis Energy, Inc. (OTC: LLEXQ) (the “Company”), an exploration and development company operating in the Permian Basin of West Texas and Southeastern New Mexico, today announced that, following a comprehensive sale process and a competitive auction as part of its Chapter 11 process, Ameredev Texas LLC has been named as the winning bidder to acquire substantially all of the Company’s assets for a $46.6 million cash payment at closing.In accordance with the bidding procedures approved by the United States Bankruptcy Court for the Southern District of Texas, Houston Division (the “Bankruptcy...
Conversion Labs to Host Third Quarter Conference Call on Monday, November 16, 2020 at 4:30 p.m. ET
Written by Customer Service on . Posted in Public Companies.
NEW YORK, Nov. 09, 2020 (GLOBE NEWSWIRE) — Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, November 16, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2020. The financial results will be issued in a press release prior to the call.Conversion Labs management will host the conference call followed by a question and answer period.Date: Monday, November 16, 2020Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number: 1-800-430-8332International dial-in number: 1-720-452-9103Conference ID: 9683420The conference call will be webcast live and available for replay here as well as via a link in the Investors section of the company’s website at ir.conversionlabs.com.Please...
BJ’s Restaurants, Inc. Appoints Bina Chaurasia to its Board of Directors
Written by Customer Service on . Posted in Public Companies.
HUNTINGTON BEACH, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — BJ’s Restaurants, Inc. (NASDAQ: BJRI) today announced the appointment of Ms. Bina Chaurasia to the Company’s Board of Directors as an independent director, effective November 6, 2020. Additionally, Ms. Chaurasia will serve as a member of the Compensation Committee of the Board. The appointment of Ms. Chaurasia brings the total number of the Company’s board members to eleven.Ms. Chaurasia currently serves as the Chief Administrative Officer and Chief People Officer of Tanium, a privately held endpoint security and systems management company based in Emeryville, California, where she is responsible for human resources, global real estate and facilities, and global enablement. Ms. Chaurasia was previously the Chief Human Resources Officer at Ericsson. She joined Ericsson...
ADLPartner : Déclaration des transactions sur actions propres réalisées du 2 au 6 novembre 2020
Written by Customer Service on . Posted in Public Companies.
ADLPartnerSociété anonyme à directoire et conseil de surveillance au capital de 6 478 836 euros3, avenue de Chartres 60500 – CHANTILLY393 376 801 R.C.S. CompiègneDéclaration des transactions sur actions propres réalisées du 2 au 6 novembre 2020Présentation agrégée par jour et par marchéDétail transaction par transactionRelations Investisseurs & Informations financièresTel : +33 1 41 58 72 03 – Courriel : relations.investisseurs@adlpartner.frADLPartner est cotée sur Euronext Paris – Compartiment CCodes ISIN : FR0000062978-ALP – Bloomberg : ALP FP – Reuters : ALDP.PAwww.adlpartner.comPièce jointeADLPartner_rachats_actions_09112020
Combined General Meeting of November 10, 2020, held in closed session & composition of the General Meeting’s Bureau
Written by Customer Service on . Posted in Public Companies.
Paris, Amsterdam, November 9, 2020Press releaseCombined General Meeting of November 10, 2020, held in closed sessionComposition of the General Meeting’s BureauIn the context of the Combined General Meeting of November 10, 2020, which will be held in closed session at the registered office of Unibail-Rodamco-Westfield SE and in accordance with the provisions of Decree No. 2020-418 of April 10, 2020, the Management Board decided to appoint Mr. Philippe Collombel, member of the Supervisory Board, and Mr. Jean-Marie Tritant, President US and SMT member, as scrutineers.The Chairman of the Supervisory Board, Mr. Colin Dyer, will chair the General Meeting.Mr. David Zeitoun, Group General Councel, will act as secretary of the General Meeting.For further information, please contact:Investor Relations Samuel WarwoodMaarten Otte +33 1 76 77 58 02 Maarten.Otte@urw.comAbout...
Assemblée Générale Mixte des actionnaires du 10 novembre 2020 à huis clos & composition du Bureau de l’Assemblée
Written by Customer Service on . Posted in Public Companies.
Paris, Amsterdam, le 9 novembre 2020Communiqué de presseAssemblée Générale Mixte des actionnaires du 10 novembre 2020 à huis closComposition du Bureau de l’AssembléeDans le cadre de l’Assemblée Générale Mixte des actionnaires du 10 novembre 2020 qui se tiendra à huis clos au siège social d’Unibail-Rodamco-Westfield SE et conformément aux dispositions du Décret n° 2020-418 du 10 avril 2020, le Directoire a désigné Monsieur Philippe Collombel, membre du Conseil de surveillance, et Monsieur Jean-Marie Tritant, Président US et membre du Comité de direction, pour assurer les fonctions de scrutateurs.Le Président du Conseil de surveillance, Monsieur Colin Dyer, présidera l’Assemblée.Monsieur David Zeitoun, Directeur Juridique Groupe, assurera les fonctions de secrétaire de l’Assemblée.Pour toute information complémentaire, veuillez contacter...